Janux Therapeutics, Inc.

JANX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Apr 29, 2026
8-K Apr 28, 2026 8-K
ARS Apr 28, 2026 ARS
DEFA14A Apr 28, 2026 DEFA14A
DEF 14A Apr 28, 2026 DEF 14A
144 Apr 13, 2026
144 Apr 2, 2026
S-8 Feb 26, 2026 S-8
10-K Feb 26, 2026 10-K
8-K Feb 26, 2026 8-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G Feb 9, 2026
SCHEDULE 13G Feb 6, 2026
4 Feb 4, 2026
3 Feb 4, 2026
144 Jan 26, 2026
144 Jan 23, 2026
8-K Jan 22, 2026 8-K
SCHEDULE 13G/A Jan 8, 2026
4 Jan 2, 2026
4 Jan 2, 2026
4 Jan 2, 2026
4 Jan 2, 2026
4 Jan 2, 2026
4 Jan 2, 2026
← Newer Page 2 of 18 · 440 filings Older →